Stereotaxis
Stereotaxis develops robotic cardiology instrument navigation systems that enhances the treatment of arrhythmias and coronary diseases. Learn more
Launch date
Employees
Market cap
AUD288m
Enterprise valuation
AUD282m (Public information from Sep 2024)
Share price
$2 STXS
Saint-Louis Département de Saint-Louis (HQ)
Authorizing premium user...